PAREXEL International Profile

Performance

   

Odds of Distress

13%13%
Check how we calculate scores
Equity ratings for PAREXEL International Corp are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting August 21, 2019 and ending today November 19, 2019. Click here to learn more.
PAREXEL International Corp cannot be verified against its exchange. Apparently, PAREXEL International is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

PAREXEL International Profile

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide.. The public information regarding PAREXEL International Corp's current market price is not available at this time.
NamePAREXEL International Corp
CEOEllen ZaneView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address195 West Street, Waltham, MA 02451, United States
ExchangeNASDAQ
CIK Number0000799729
ISINUS6994621075
BenchmarkDOW
Websitewww.parexel.com
Phone781 487 9900
PAREXEL International Corp (PRXL) is traded on NASDAQ in USA and employs 18,600 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 4.5 B. PAREXEL International conducts business under null sector and is part of null industry. The entity has 51.12 M outstanding shares of which 506.64 K shares are at this time shorted by private and institutional investors with about 0.57 trading days to cover. PAREXEL INTL CP currently holds about 302.7 M in cash with 306.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.92.
Check PAREXEL International Probability Of Bankruptcy

PAREXEL International Top Holders

PAREXEL International Key Fundamentals

PAREXEL International Against Markets

PAREXEL International Corp cannot be verified against its exchange. Apparently, PAREXEL International is not available for investing at the moment. Please verify the symbol is currently traded on NASDAQ. If you still believe the symbol you are trying to look up is valid please let us know and we will check it as soon as possible.
Refesh

Try Other Stock Suggestions

PAREXEL International Corporationration, a biopharmaceutical services company, offer clinical research, clinical logistics, medical communications, consulting, commercialization, and advanced technology solutions and services for pharmaceutical, biotechnology, and medical device industries worldwide.. The public information regarding PAREXEL International Corp's current market price is not available at this time.
NamePAREXEL International Corp
CEOEllen ZaneView All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Pharmaceuticals And Biosciences
InstrumentUSA Stock View All
RegionNorth America
Business Address195 West Street, Waltham, MA 02451, United States
ExchangeNASDAQ
CIK Number0000799729
ISINUS6994621075
BenchmarkDOW
Websitewww.parexel.com
Phone781 487 9900

PAREXEL International Corporate Directors

Dana Callow Presiding Independent Director
Patrick Fortune Independent Director
Eduard Holdener Independent Director
See also Your Equity Center. Please also try Portfolio Reporting module to create custom reports across your portfolios and generate quick suggestion pitch.
Search macroaxis.com